No Data
Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), AMN Healthcare Services (AMN) and 4D Molecular Therapeutics (FDMT)
Express News | NYSE Order Imbalance 53497.0 Shares on Buy Side
AMN Healthcare Is Maintained at Outperform by BMO Capital
AMN Healthcare Is Maintained at Outperform by BMO Capital
Buy Rating Affirmed for AMN Healthcare Services Amidst Cautious Optimism and Expected Turnaround
Express News | AMN Healthcare Services Inc : BMO Cuts Target Price to $71 From $80
AMN Healthcare Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions